1. EMA: no safety concerns with recommended biosimilars

   Guideline 27 May 2017 Pages: 1 - 1

2. Label changes for antihistamines after public consultation

   News item 27 May 2017 Pages: 2 - 2

3. Medsafe monitoring safety of DAAs following liver failure reports

   News item 27 May 2017 Pages: 3 - 3

4. US FDA confirms amputation risks with canagliflozin

   News item 27 May 2017 Pages: 4 - 4

5. Brexit: serious consequences for drug regulation and PV in UK

   Comment 27 May 2017 Pages: 5 - 5

6. Aromatic antiepileptics: haplotypes associated with SJS/TEN

   Clinical study 27 May 2017 Pages: 6 - 6

7. FAERS reports of diabetic ketoacidosis with SGLT2 inhibitors

   Clinical study 27 May 2017 Pages: 7 - 7

8. Long-term quinine exposure associated with increased mortality

   Clinical study 27 May 2017 Pages: 8 - 8

9. Paediatric cough & cold medication: low adverse event rate

   Clinical study 27 May 2017 Pages: 9 - 9

10. Phosphodiesterase inhibitors and melanoma: meta-analysis

    Clinical study 27 May 2017 Pages: 10 - 10

11. Survey of verbal risk descriptor understanding

    Clinical study 27 May 2017 Pages: 11 - 11

12. 18f-fluoroestradiol

    Case report 27 May 2017 Pages: 12 - 12

13. Aceclofenac

    Case report 27 May 2017 Pages: 13 - 13

14. Acetazolamide

    Case report 27 May 2017 Pages: 14 - 14

15. Acetazolamide/brinzolamide

    Case report 27 May 2017 Pages: 15 - 15

16. Acitretin

    Case report 27 May 2017 Pages: 16 - 16

17. Adalimumab

    Case report 27 May 2017 Pages: 17 - 17

18. Adalimumab

    Case report 27 May 2017 Pages: 18 - 18

19. Adalimumab

    Case report 27 May 2017 Pages: 19 - 19

20. Adalimumab

    Case report 27 May 2017 Pages: 20 - 20

21. Adalimumab

    Case report 27 May 2017 Pages: 21 - 21

22. Adalimumab

    Case report 27 May 2017 Pages: 22 - 22

23. Adalimumab/ceftriaxone/pantoprazole

    Case report 27 May 2017 Pages: 23 - 23

24. Adalimumab/methotrexate

    Case report 27 May 2017 Pages: 24 - 24

25. Adenosine

    Case report 27 May 2017 Pages: 25 - 25

26. Afatinib/gefitinib

    Case report 27 May 2017 Pages: 26 - 26

27. Alcohol

    Case report 27 May 2017 Pages: 27 - 27

28. Alemtuzumab

    Case report 27 May 2017 Pages: 28 - 28

29. Alendronic acid/corticosteroids/methotrexate

    Case report 27 May 2017 Pages: 29 - 29

30. Allopurinol

    Case report 27 May 2017 Pages: 30 - 30

31. Alprazolam/quetiapine overdose

    Case report 27 May 2017 Pages: 31 - 31

32. Alprostadil

    Case report 27 May 2017 Pages: 32 - 32

33. Alteplase

    Case report 27 May 2017 Pages: 33 - 33

34. Amikacin

    Case report 27 May 2017 Pages: 34 - 34

35. Amikacin

    Case report 27 May 2017 Pages: 35 - 35

36. Amikacin/ethambutol

    Case report 27 May 2017 Pages: 36 - 36

37. Amiodarone

    Case report 27 May 2017 Pages: 37 - 37

38. Amiodarone

    Case report 27 May 2017 Pages: 38 - 38

39. Amoxicillin/clarithromycin

    Case report 27 May 2017 Pages: 39 - 39

40. Amoxicillin/clavulanic-acid/atorvastatin

    Case report 27 May 2017 Pages: 40 - 40

41. Amphotericin B/fluconazole

    Case report 27 May 2017 Pages: 41 - 41

42. Anakinra

    Case report 27 May 2017 Pages: 42 - 42

43. Anakinra/canakinumab

    Case report 27 May 2017 Pages: 43 - 43

44. Anastrozole

    Case report 27 May 2017 Pages: 44 - 44

45. Anticoagulants/bevacizumab

    Case report 27 May 2017 Pages: 45 - 45

46. Antineoplastics

    Case report 27 May 2017 Pages: 46 - 46

47. Antineoplastics

    Case report 27 May 2017 Pages: 47 - 47

48. Antineoplastics

    Case report 27 May 2017 Pages: 48 - 48

49. Antineoplastics

    Case report 27 May 2017 Pages: 49 - 49

50. Antithymocyte-globulin

    Case report 27 May 2017 Pages: 50 - 50